Ihilov Hospital specializes in the study and treatment of rare pathologies, including heavy chain diseases (HCD). The effectiveness of treating alpha heavy chain disease in Israel is ensured by the combination of experience and high qualifications of medical staff, practical results of scientific research, and modern technologies. The clinic employs top-notch specialists, including hematologists and oncologists, capable of diagnosing and managing complex and rare conditions such as heavy chain disease.
Individual therapeutic courses include multifactorial analysis, including genetic and molecular characteristics of the disease. Ihilov utilizes the latest advancements in medical science: innovative immunotherapy methods, monoclonal antibodies, and personalized chemotherapy regimens.
The medical institution is equipped with the latest models of diagnostic and therapeutic devices. A multidisciplinary team of professionals, including hematologists, oncologists, and radiologists, develops a treatment strategy for each patient. The medical center actively participates in the development and clinical trials of new drugs and treatment methods, having significant experience in successful bone marrow and stem cell transplants.
About the Disease
Alpha heavy chain disease is one of the subtypes of heavy chain immunoglobulin disease. The pathology is classified as a type of paraprotenemic hemoblastosis associated with chronic lymphocytic leukemias. The disease is characterized by disturbances in the process of immunoglobulin formation, resulting in fragments of heavy immunoglobulin chains appearing in the blood and urine—atypical proteins known as paraproteins.
α-HCD represents a pathology of plasma cells and manifests as an abnormal synthesis process with fragmented secretion of heavy chains. Modern medicine is still searching for explanations for the failures in structural genes that lead to errors in immunoglobulin coding.
Clinical manifestations of Franklin's disease can vary widely but generally correspond to the symptoms of lymphoma or other lymphoproliferative diseases, including anemia, weight loss, fatigue, and malaise. Alpha heavy chain disease may manifest through protein loss in the gastrointestinal tract, leading to hypoproteinemia.
Treatment Methods for the Disease
Not every medical center has staff capable of recognizing and prescribing adequate treatment for this complex and rare disease. The doctors at Ihilov have practical experience in diagnosing and treating alpha heavy chain disease. Therapeutic strategies are developed individually for each case. Typically, treatment is based on a combination of corticosteroids, cytotoxic agents, and broad-spectrum antibiotics. Years of practice at Ihilov show that appropriately selected methods ensure remission and a positive prognosis.
Chemotherapy
Treatment of heavy alpha chain immunoglobulin disease involves a systemic approach to the use of chemotherapeutic agents. The goal is to eliminate pathological cells and stop the formation of new ones. The oncologist develops an individual chemotherapy program based on the stage of the disease, the current health of the patient, and the response to previous therapies. Protocols are tailored to the needs of each patient.
To enhance effectiveness and control side effects, an escalation dosing strategy shows results. This method involves increasing the dosage of chemotherapeutic agents until the desired effect is achieved. The use of multiple drugs in combination allows for attacking abnormal cells at different phases of their life cycle, increasing the likelihood of their complete destruction.
Chemotherapy is conducted in cycles with alternating active periods and rest for recovery.
Steroids
Steroid therapy is one of the components of a comprehensive approach. It suppresses the abnormal proliferation of B-lymphocytes, reduces inflammation, and associated manifestations.
Initially, patients are prescribed steroids in high doses. After achieving optimal effect, the doctor adjusts the dosage and duration of administration based on the severity of the disease and the patient's condition. Medications are prescribed orally, in tablet form, or through intravenous injections.
As progress is made, the dosage is gradually reduced to minimize side effects and potential complications. After achieving stable remission, maintenance therapy with reduced doses of steroids may be prescribed to maintain achieved results and prevent disease relapses.
Targeted Therapy
Targeted therapy for alpha heavy chain disease focuses on impacting specific molecular targets that play a key role in the growth and survival of atypical cells. Unlike traditional chemotherapy, which aims for the general destruction of atypical cells, this method uses inhibitors and other molecular agents designed to interact with specific molecules and signaling pathways. Target mutations and targets for the application of such drugs are strictly individual and selected based on the characteristics of each case.
Monoclonal Antibody Therapy
In the fight against rare types of lymphoproliferative disorders, treatment with monoclonal antibodies shows effectiveness. These are specific proteins created in laboratory conditions. Their main goal is to activate the immune system and prompt it to attack specific targets on the surface of malignant cells.
The peculiarity of the approach to syndromes associated with defective immunoglobulins is that monoclonal antibodies are directed at specific antigens. The body is directed to a target present on the surface of abnormal B-lymphocytes or to additional biomarkers related to the maintenance of the viability and proliferation of such cells.
To prescribe such treatment, an analysis of cancer cell biomarkers of the specific patient is conducted, based on which a monoclonal antibody is created.
Stem Cell Transplantation
In certain cases, stem cell transplantation may be included in the treatment plan. At Ihilov, transplants are performed in two ways:
- autologous transplantation, in which the patient's own stem cells are returned after being purified and processed. This procedure is most often performed after high-dose chemotherapy and radiotherapy. The main goal of the procedure is to eliminate cells producing pathogenic paraprotein and stimulate the recovery of healthy bone marrow function.
- in allogeneic transplantation, stem cells are obtained from a suitable donor. This procedure helps form a new immune system in the patient, increasing the ability to fight pathological cells.
Transplantation is resorted to when other therapeutic approaches are insufficiently effective and if the disease recurs.
- Stem Cell Treatment
- Chemotherapy
Diagnosis Methods for the Disease
To accurately identify this rare disease, a combined diagnosis is conducted at the Ihilov medical center. Typically, the full cycle of testing and analysis takes three days.
First Day
The doctor conducts a thorough medical history collection and assesses symptoms. During a complete physical examination, lymph nodes and the abdominal cavity are checked for signs of lymphadenopathy or enlargement of the liver and spleen.
Second Day
- Blood tests. The main diagnostic test is a serological analysis to detect paraproteins and deviations in the quantity and quality of immunoglobulins.
- Urine analysis. Among other tests, the presence of Bence-Jones protein is determined, indicating the presence of light chains of immunoglobulins.
- Specific studies to assess the functioning of systems and organs to evaluate overall health indicators.
- Immunochemical test. This study determines the class of immunoglobulins, identifies light and heavy chains, and the presence and quantity of their fragments.
- A series of biochemical studies to identify changes associated with the disease, including anemia, kidney dysfunction, and other accompanying signs.
- Bone marrow biopsy analysis. If necessary, a biopsy with subsequent histological examination of the bone marrow is performed to identify plasmacytic infiltration or other deviations.
- Radiological examination. X-rays, CT scans, or MRIs may be used to identify damage to bone tissue or enlargement of lymph nodes.
- Histological examination. Conducted on tissue samples taken from the liver, lymph nodes, and intestines.
Third Day
The diagnosis is confirmed after analyzing all physiological, laboratory, and instrumental tests. The determining factor for diagnosing alpha heavy chain disease is the detection of IgA chain fragments in the serum. At the Ihilov medical center, a council of doctors from various specialties works on interpreting diagnostic data. This multidisciplinary approach ensures a comprehensive analysis of symptoms, accurate assessment of examination results, and the development of the most effective treatment plan.
- Bone Marrow Biopsy
- Computed Tomography
- Magnetic Resonance Imaging (MRI)
- X-ray
- Blood Biochemistry
How Much Does Treatment Cost
The treatment protocol for α-HCD is formed individually and depends on a number of parameters. The final cost of the treatment course is determined based on the stage of the disease, clinical manifestations, the current health status of the patient, and their response to initial therapy. Considering the unique details of each specific case allows the Ihilov medical team to select the best therapeutic methods, guided by the latest clinical guidelines and research. The final price of therapy consists of the volume and complexity of the necessary diagnostic procedures and treatment manipulations.
For information on how much the treatment course costs at the Ihilov medical center, contact a qualified coordinator. The medical consultant will provide information on treatment methods, help you review feedback on doctors and their ratings, and clarify all organizational and financial aspects. You can get a consultation through the online chat, by filling out a form on the website, or by phone.
Advantages of Treating Alpha Heavy Chain Disease in Israel
- Professionalism and practical experience of medical staff.
- Individual approach to each patient, application of advanced treatment methods, and use of modern medical equipment.
- Collaboration within multidisciplinary teams of specialists, clinical research, and trials of new therapies.
- Experience in performing stem cell transplants and other innovative treatment methods.
- Comprehensive support for international patients, high level of comfort during stay, and high-quality medical care.